NCT06165250 - A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C | Biotech Hunter

Enrollment

156

Participants

Timeline

Start Date

April 17, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Essential HypertensionPrimary Hypercholesterolemia

Interventions

DRUG

BR1018A

One tablet administered alone

DRUG

BR1018A-1

One tablet administered alone

DRUG

BR1018B

One tablet administered alone

DRUG

BR1018B-1

One tablet administered alone

DRUG

BR1018C

One tablet administered alone

DRUG

BR1018C-1

One tablet administered alone

Trial Locations (2)

RECRUITING

Keimyung University Dongsan Hospital, Daegu

RECRUITING

Seoul National University Boramae Medical Center, Seoul